Secondary Outcome(s)
|
Number of joints with limitation of motion at each visit.
[Time Frame: up to 8 years]
|
In subjects with Enthesitis Related Arthritis (ERA): Change from baseline in the Tender Entheseal Assessment, Modified Schober's Test, Overall Back Pain and Nocturnal Back Pain responses at various visits.
[Time Frame: up to 8 years]
|
Number of joints with active arthritis at each visit.
[Time Frame: up to 8 years]
|
Parent's Assessment of Physical Function (Childhood Health Assessment Questionnaire [CHAQ]Disability Index)at each visit.
[Time Frame: up to 8 years]
|
Parent's Global Assessment of Overall Wellbeing (Childhood Health Assessment Questionnaire [CHAQ] subsection, Visual Analog Scale [VAS])at each visit.
[Time Frame: up to 8 years]
|
Change from baseline in Juvenile Arthritis Disease Activity Score (JADAS) 27- CRP and JADAS 27-ESR, and occurrence of JADAS minimum disease activity and inactive disease at each visit.
[Time Frame: up to 8 years]
|
Eligibility of tapering defined per protocol for corticosteroids
[Time Frame: up to 8 years]
|
Eligibility of tapering defined per protocol for leflunomide
[Time Frame: Up to 8 years]
|
Eligibility of tapering defined per protocol for methotrexate
[Time Frame: up to 8 years]
|
Eligibility of tapering defined per protocol for tofacitinib
[Time Frame: Up to 8 years]
|
In subjects with psoriatic arthritis (PsA): Change from baseline in body surface area (BSA) affected by psoriasis and Physician's Global Assessment (PGA) of psoriasis) at various visits.
[Time Frame: up to 8 years]
|
Parent's Assessment of Child's Arthritis Pain (Childhood Health Assessment Questionnaire [CHAQ] Discomfort Index, Visual Analog Scale [VAS])at each visit.
[Time Frame: up to 8 years]
|
JIA ACR Clinical Inactive Disease status and Clinical Remission on Medication at each visit.
[Time Frame: up to 8 years]
|
Physician global evaluation of disease activity at each visit.
[Time Frame: up to 8 years]
|
Index of inflammation (C-reactive protein [CRP] and Erythrocyte Sedimentation Rate [ESR]) at each visit.
[Time Frame: up to 8 years]
|
JIA American College of Rheumatology (ACR) response and occurrence of JIA ACR disease flare at each visit.
[Time Frame: up to 8 years]
|
In subjects with sJIA: "Absence of Fever", defined as absence of fever due to sJIA in the week preceding the assessment at each visit.
[Time Frame: up to 8 years]
|